Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY10.27 CNY
Change Today -0.33 / -3.11%
Volume 19.3M
600216 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang medicine co ltd-a (600216) Snapshot

Open
CNY10.55
Previous Close
CNY10.60
Day High
CNY10.77
Day Low
CNY10.22
52 Week High
06/12/15 - CNY17.96
52 Week Low
07/9/15 - CNY8.18
Market Cap
9.6B
Average Volume 10 Days
30.0M
EPS TTM
CNY0.05
Shares Outstanding
936.1M
EX-Date
07/23/15
P/E TM
201.0x
Dividend
CNY0.06
Dividend Yield
0.58%
Current Stock Chart for ZHEJIANG MEDICINE CO LTD-A (600216)

Related News

No related news articles were found.

zhejiang medicine co ltd-a (600216) Related Businessweek News

No Related Businessweek News Found

zhejiang medicine co ltd-a (600216) Details

Zhejiang Medicine Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical preparations in China and internationally. It primarily produces fat-soluble vitamins, quasi-vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products. The company also provides glycopeptides medicines, natural drugs, food and feed additives, biological medicines and pesticides, and pharmaceutical intermediates, as well as human and animal nutrition products. Zhejiang Medicine Co., Ltd. was founded in 1954 and is based in Shaoxing, China.

Founded in 1954

zhejiang medicine co ltd-a (600216) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang medicine co ltd-a (600216) Key Developments

Zhejiang Medicine Co., Ltd. Announces Implementation of the Scheme for Profit Distribution 2014, Payable on July 23, 2015

Zhejiang Medicine Co., Ltd. announced that the company implemented the scheme for profit distribution 2014 of RMB 0.6 (taxes included) for every 10 shares. Record date is July 22, 2015, ex-dividend date is July 23, 2015 and cash dividend payable on July 23, 2015.

Zhejiang Medicine Co., Ltd., Board Meeting, Jun 11, 2015

Zhejiang Medicine Co., Ltd., Board Meeting, Jun 11, 2015. Agenda: To consider issue of electing chairman and vice chairman of seventh directorate; to consider the letter of nomination of appointment of president and secretary to directorate of seventh directorate; and to consider the letter of nomination of appointment of members of senior management of seventh directorate.

Zhejiang Medicine Co., Ltd. Approves Amendments to its Articles of Association

Zhejiang Medicine Co., Ltd. held its Annual General Meeting of 2014 on June 11, 2015. At the meeting, the shareholders approved amendments to the company's articles of association.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600216:CH CNY10.27 CNY -0.33

600216 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Nanjing Sinolife United Co Ltd $3.42 HKD -0.12
View Industry Companies
 

Industry Analysis

600216

Industry Average

Valuation 600216 Industry Range
Price/Earnings 100.0x
Price/Sales 2.1x
Price/Book 1.5x
Price/Cash Flow 202.0x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG MEDICINE CO LTD-A, please visit www.china-zmc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.